Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI

Conditions: Neurocognitive Dysfunction Interventions: Drug: Memantine Oral Tablet Sponsors: Tata Memorial Centre Not yet recruiting

Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials